Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study

Dilmen, Ugur; ÖZDEMİR, RAMAZAN; Aksoy, Hatice; Uras, Nurdan; Demirel, Nihal; Kirimi, Ercan; ERDEVE, ÖMER; Ozer, Esra; Bas, Ahmet; Gursoy, Tugba; Zenciroglu, Aysegul; Ovali, Fahri; Oguz, S.

doi:10.3109/14767058.2013.818120

Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study

Copy For Citation

Dilmen U., ÖZDEMİR R., Aksoy H. T., Uras N., Demirel N., Kirimi E., ...More

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, vol.27, no.4, pp.411-415, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 27 Issue: 4
Publication Date: 2014
Doi Number: 10.3109/14767058.2013.818120
Journal Name: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.411-415
Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Objective: Surfactant treatment in the early hours of life significantly decreases the rates of death and air leak, and increases survival without bronchopulmonary dysplasia (BPD) in preterm infants. We aimed to compare the impact of early surfactant (ES) administration to late selective (LS) treatment on neonatal outcomes in preterm infants.